Opportunity Information: Apply for PAR 19 258
The NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed), funding opportunity number PAR-19-258, is a National Institutes of Health discretionary grant program designed to strengthen the research education pipeline in areas aligned with NIH and National Institute on Drug Abuse (NIDA) priorities. It uses the NIH R25 mechanism, which is specifically meant to support structured research education activities rather than standard research projects or routine clinical training. The central purpose of this opportunity is to build and improve the workforce needed to meet the United States' biomedical, behavioral, and clinical research needs, with this particular announcement focusing on substance use and substance use disorder (SUD) research.
A key feature of the program is its emphasis on clinically oriented participants. The intended audience includes people already in clinically focused careers and individuals preparing for careers as clinicians or health service providers, clinical researchers, or ideally professionals who combine clinical practice with research responsibilities. In practical terms, the grant supports educational experiences that deepen participants knowledge and skills in substance use and SUD research, helping clinicians and clinician-researchers better understand the science behind prevention, diagnosis, treatment, recovery, and the broader public health impact of substance use. While the grant is meant to enhance research-related competencies, it explicitly cannot be used to pay for non-research-related clinical training, meaning it is not intended to fund typical clinical rotations, licensure requirements, or purely service-oriented training that is not directly tied to research education goals.
This opportunity is categorized under education and health and is associated with CFDA number 93.279. The funding instrument is a grant, and the listed award ceiling is $350,000. The sponsoring agency is the National Institutes of Health. Based on the information provided, the original closing date was August 11, 2021, and the opportunity record indicates a creation date of April 23, 2019.
Eligibility is broad and includes many types of organizations that can carry out research education programming. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; tribal organizations that are not federally recognized governments; and a range of nonprofit and for-profit entities, including small businesses. The announcement also highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). This breadth reflects an intention to reach diverse training environments and expand research education capacity across different communities and institutional settings.
Overall, PAR-19-258 is best understood as a workforce development and research education grant focused on improving the knowledge base and research readiness of clinicians and clinical researchers working in or entering the substance use and SUD field. It is aimed at strengthening research education offerings that complement existing career pathways, expanding the number of professionals who can contribute to evidence-based advances in substance use science, and doing so through formal educational activities rather than clinical service training or clinical trials.Apply for PAR 19 258
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2019-04-23.
- Applicants must submit their applications by 2021-08-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $350,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)?
It is a National Institutes of Health (NIH) discretionary grant opportunity sponsored by the National Institute on Drug Abuse (NIDA) that uses the NIH R25 mechanism to support structured research education activities. The focus of this specific announcement (PAR-19-258) is strengthening the research education pipeline in areas aligned with NIH and NIDA priorities, with an emphasis on substance use and substance use disorder (SUD) research.
What is the funding opportunity number for this program?
The funding opportunity number is PAR-19-258.
What is the main goal of this grant opportunity?
The central purpose is workforce development through research education: building and improving the workforce needed to meet U.S. biomedical, behavioral, and clinical research needs. Under this announcement, that goal is pursued by improving the knowledge and research readiness of clinicians and clinical researchers in substance use and SUD research.
What kinds of activities does the NIH R25 mechanism support in this program?
This program supports structured research education activities rather than standard research projects or routine clinical training. In other words, it is designed to fund educational experiences that strengthen research-related knowledge and skills, particularly in substance use and SUD research.
Is this grant intended to fund a standard research project?
No. The R25 mechanism is meant to support research education programming and structured educational activities, not typical stand-alone research projects.
Are clinical trials allowed under this opportunity?
No. The announcement is labeled "Clinical Trial Not Allowed," meaning the program is not intended to support clinical trials.
Who is the intended audience for the research education supported by this grant?
The program emphasizes clinically oriented participants. This includes people already in clinically focused careers and individuals preparing for careers as clinicians or health service providers, clinical researchers, or professionals who combine clinical practice with research responsibilities.
What topic areas are emphasized by this opportunity?
The announcement focuses on substance use and substance use disorder (SUD) research, including the science behind prevention, diagnosis, treatment, recovery, and the broader public health impact of substance use.
Can the grant be used to pay for routine clinical training or clinical rotations?
No. The opportunity explicitly states it cannot be used to pay for non-research-related clinical training. It is not intended to fund typical clinical rotations, licensure requirements, or purely service-oriented training that is not directly tied to research education goals.
What is the funding instrument for this opportunity?
The funding instrument is a grant.
What is the maximum award amount (award ceiling) listed for this opportunity?
The listed award ceiling is $350,000.
Which federal agency sponsors this opportunity?
The sponsoring agency is the National Institutes of Health (NIH), and the program is associated with the National Institute on Drug Abuse (NIDA).
What category is this opportunity associated with?
It is categorized under education and health.
What is the CFDA number associated with this program?
The CFDA number listed is 93.279.
When was this opportunity record created?
The opportunity record indicates a creation date of April 23, 2019.
What was the original closing date listed for this opportunity?
Based on the information provided, the original closing date was August 11, 2021.
What types of organizations are eligible to apply?
Eligibility is broad and includes many types of organizations capable of delivering research education programming. Eligible applicants include:
- State, county, and local governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Federally recognized Native American tribal governments
- Public housing authorities and Indian housing authorities
- Tribal organizations that are not federally recognized governments
- Nonprofit entities
- For-profit entities, including small businesses
Are minority-serving institutions and other specific institution types eligible?
Yes. The announcement highlights additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).
Can faith-based or community-based organizations apply?
Yes. Faith-based or community-based organizations are listed among eligible applicant types.
Can federal agencies apply?
Yes. Eligible federal agencies are listed as eligible applicants.
Are U.S. territories or possessions eligible to apply?
Yes. Regional organizations and U.S. territories or possessions are included among eligible applicant categories.
Are non-U.S. (foreign) organizations eligible?
Yes. The opportunity includes non-U.S. entities (foreign organizations) among eligible applicants.
What is the overall intent of PAR-19-258 in plain terms?
PAR-19-258 is best understood as a workforce development and research education grant. Its purpose is to expand and strengthen substance use and SUD research education offerings that complement existing clinical and clinical-research career pathways, increasing the number of professionals prepared to contribute to evidence-based advances in substance use science through formal research education activities (not clinical service training or clinical trials).
Browse more opportunities from the same category: Education, Health
Next opportunity: PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required
Previous opportunity: Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 19 258
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 19 258) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) Apply for PAR 19 259 Funding Number: PAR 19 259 Agency: National Institutes of Health Category: Education, Health Funding Amount: $10,000,000 |
| Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01 Clinical Trial Not Allowed) Apply for RFA DA 20 005 Funding Number: RFA DA 20 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) Apply for PAR 19 264 Funding Number: PAR 19 264 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 041 Funding Number: RFA AI 19 041 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) Apply for PAR 19 277 Funding Number: PAR 19 277 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Blockchain Technology to Improve SUD Care (R43/R44 - Clinical Trial Optional) Apply for RFA DA 20 012 Funding Number: RFA DA 20 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Blockchain Technology to Improve SUD Care (R41/R42 - Clinical Trial Optional) Apply for RFA DA 20 011 Funding Number: RFA DA 20 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) Apply for PAR 19 278 Funding Number: PAR 19 278 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional) Apply for PAR 19 279 Funding Number: PAR 19 279 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 20 017 Funding Number: RFA DA 20 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional) Apply for PAR 19 280 Funding Number: PAR 19 280 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) Apply for RFA DA 20 018 Funding Number: RFA DA 20 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed) Apply for PAR 19 285 Funding Number: PAR 19 285 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) Apply for PAR 19 283 Funding Number: PAR 19 283 Agency: National Institutes of Health Category: Education, Health Funding Amount: $280,000 |
| Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed) Apply for PAR 19 284 Funding Number: PAR 19 284 Agency: National Institutes of Health Category: Education, Health Funding Amount: $28,000 |
| Rapid Assessment of Drug Abuse: Smart City Tools (R41/R42 - Clinical Trial Optional) Apply for RFA DA 20 020 Funding Number: RFA DA 20 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 19 282 Funding Number: PAR 19 282 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Rapid Assessment of Drug Abuse: Smart City Tools (R43/R44 - Clinical Trial Optional) Apply for RFA DA 20 021 Funding Number: RFA DA 20 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional) Apply for RFA DA 20 013 Funding Number: RFA DA 20 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Workshops on the Use of Adolescent Brain Cognitive Development (ABCD) Data (R25 Clinical Trial Not Allowed) Apply for RFA DA 20 001 Funding Number: RFA DA 20 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 258", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.